InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Browse the detailed record of transactions filed by Giffin Brett A., Directeur Commercial. Director active across 1 company, notably T2 Biosystems, Inc.. In total, 6 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €5k. History available since 8 April 2022. The latest transaction was disclosed on 8 April 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Giffin Brett A. is Directeur Commercial and Chief Commercial Officer at T2 Biosystems, Inc. He has 6 filings in total, and across the recent filings available, purchases total EUR 4771 with no sales, covering the period from 2022-04-11 to 2024-02-20. The most common transaction type is option exercise.